Juha O Rinne Selected Research

Juha O Rinne Research Topics

Disease

59	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 12/2002
26	Cognitive Dysfunction 11/2022 - 12/2008
25	Parkinson Disease (Parkinson's Disease) 01/2023 - 10/2002
22	Dementia (Dementias) 01/2022 - 11/2008
16	Neuroinflammatory Diseases 01/2023 - 02/2010
10	Inflammation (Inflammations) 01/2023 - 03/2010
8	Insulin Resistance 12/2023 - 11/2015
6	Atrophy 05/2024 - 11/2008
6	Amyloid Plaque 12/2023 - 02/2010
5	Normal Pressure Hydrocephalus 01/2019 - 12/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2010
3	Type 2 Diabetes Mellitus (MODY) 11/2022 - 01/2017
3	Amyloidosis 01/2018 - 12/2012
3	Disease Progression 01/2018 - 11/2008
2	Hypertension (High Blood Pressure) 11/2022 - 05/2017
2	Neurobehavioral Manifestations 01/2018 - 08/2011
2	Epilepsy (Aura) 11/2017 - 01/2017
2	Frontotemporal Dementia (Semantic Dementia) 01/2016 - 05/2015
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016 - 05/2015
2	Gambling (Pathological Gambling) 05/2012 - 05/2012
2	Overweight 09/2008 - 09/2007
1	Dyskinesias (Dyskinesia) 01/2023
1	Hypercholesterolemia 11/2022
1	Basal Ganglia Diseases (Basal Ganglia Disease) 01/2022
1	Synucleinopathies 01/2022
1	Weight Gain 10/2021
1	Nervous System Diseases (Neurological Disorders) 04/2021
1	Memory Disorders (Memory Loss) 04/2021
1	Obesity 04/2021
1	Brain Diseases (Brain Disorder) 12/2020
1	Tics (Tic) 12/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018
1	Lewy Body Disease (Lewy Body Dementia) 01/2018
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 12/2017
1	Tremor (Tremors) 12/2017
1	Edema (Dropsy) 05/2016

Drug/Important Bio-Agent (IBA)

37	Amyloid (Amyloid Fibrils)IBA 05/2024 - 04/2008
20	Biomarkers (Surrogate Marker)IBA 05/2024 - 08/2012
19	Apolipoproteins E (ApoE)IBA 05/2024 - 05/2015
17	Amyloid beta-PeptidesIBA 12/2023 - 11/2008
16	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2021 - 01/2008
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
14	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2003
10	Dopamine (Intropin)FDA LinkGeneric 08/2014 - 11/2002
6	ApolipoproteinsIBA 12/2023 - 09/2004
6	flutemetamolIBA 01/2018 - 11/2012
6	Levodopa (L Dopa)FDA LinkGeneric 11/2012 - 10/2002
5	Insulin (Novolin)FDA Link 04/2021 - 03/2015
5	RacloprideIBA 05/2012 - 11/2003
4	C-Reactive ProteinIBA 01/2023 - 01/2017
4	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2022 - 05/2015
3	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2023 - 09/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2021 - 08/2017
3	EnzymesIBA 01/2021 - 09/2004
3	Cholinergic Agents (Cholinergics)IBA 01/2018 - 12/2002
3	LigandsIBA 01/2017 - 03/2010
3	CarbonIBA 01/2017 - 04/2008
3	bapineuzumabIBA 05/2016 - 04/2010
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2015 - 11/2003
3	fluorodopa F 18IBA 05/2012 - 02/2001
3	AcetylcholinesteraseIBA 01/2012 - 12/2002
3	Deoxyglucose (2 Deoxy D glucose)IBA 12/2009 - 01/2003
2	Apolipoprotein E4IBA 02/2024 - 01/2023
2	Antisense OligonucleotidesIBA 10/2023 - 06/2023
2	KF18446IBA 01/2023 - 01/2021
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022 - 01/2018
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 11/2002
2	ORM-12741IBA 12/2020 - 01/2017
2	Pemetrexed (MTA)FDA Link 01/2020 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2003
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2018 - 12/2002
2	Monoclonal AntibodiesIBA 08/2012 - 04/2010
1	Apolipoprotein E3IBA 02/2024
1	VaccinesIBA 12/2023
1	UmibecestatIBA 12/2023
1	CholesterolIBA 01/2023
1	Glial Fibrillary Acidic ProteinIBA 01/2023
1	(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022
1	EndocannabinoidsIBA 01/2022
1	CannabinoidsIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	Hormones (Hormone)IBA 10/2021
1	FluorineIBA 04/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	C-PeptideIBA 01/2020
1	IronIBA 12/2017
1	LipidsIBA 05/2017
1	Cyclooxygenase InhibitorsIBA 01/2017
1	Lipoxygenase (Lipoxygenase-1)IBA 01/2017
1	ImmunosorbentsIBA 01/2016

Therapy/Procedure

3	Therapeutics 08/2017 - 02/2010
2	Immunotherapy 12/2023 - 08/2012
1	Drug Therapy (Chemotherapy) 01/2022